Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 2
1957 1
1958 9
1959 1
1963 1
1976 1
1979 1
1980 1
1982 3
1983 2
1984 1
1985 2
1986 4
1987 1
1988 4
1989 6
1990 7
1991 5
1992 8
1993 3
1994 3
1995 5
1996 5
1997 8
1998 6
1999 4
2000 10
2001 9
2002 12
2003 12
2004 15
2005 21
2006 31
2007 24
2008 28
2009 18
2010 32
2011 33
2012 36
2013 35
2014 42
2015 38
2016 41
2017 42
2018 54
2019 62
2020 68
2021 79
2022 73
2023 78
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

924 results

Results by year

Filters applied: . Clear all
Page 1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF; INDIGO Trial Investigators. Mellinghoff IK, et al. Among authors: hassan i. N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272516 Clinical Trial.
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Furie RA, Aroca G, Cascino MD, Garg JP, Rovin BH, Alvarez A, Fragoso-Loyo H, Zuta-Santillan E, Schindler T, Brunetta P, Looney CM, Hassan I, Malvar A. Furie RA, et al. Among authors: hassan i. Ann Rheum Dis. 2022 Jan;81(1):100-107. doi: 10.1136/annrheumdis-2021-220920. Epub 2021 Oct 6. Ann Rheum Dis. 2022. PMID: 34615636 Free PMC article. Clinical Trial.
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Among authors: hassan i. Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823302 Free PMC article. Clinical Trial.
Antiseptics for burns.
Norman G, Christie J, Liu Z, Westby MJ, Jefferies JM, Hudson T, Edwards J, Mohapatra DP, Hassan IA, Dumville JC. Norman G, et al. Among authors: hassan ia. Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011821. doi: 10.1002/14651858.CD011821.pub2. Cochrane Database Syst Rev. 2017. PMID: 28700086 Free PMC article. Review.
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Mellinghoff IK, et al. Among authors: hassan i. Clin Cancer Res. 2021 Aug 15;27(16):4491-4499. doi: 10.1158/1078-0432.CCR-21-0611. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078652 Free PMC article. Clinical Trial.
The gut microbiota-brain axis in neurological disorder.
Ullah H, Arbab S, Tian Y, Liu CQ, Chen Y, Qijie L, Khan MIU, Hassan IU, Li K. Ullah H, et al. Among authors: hassan iu. Front Neurosci. 2023 Aug 4;17:1225875. doi: 10.3389/fnins.2023.1225875. eCollection 2023. Front Neurosci. 2023. PMID: 37600019 Free PMC article. Review.
Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
Chu JJ, Devall AJ, Beeson LE, Hardy P, Cheed V, Sun Y, Roberts TE, Ogwulu CO, Williams E, Jones LL, La Fontaine Papadopoulos JH, Bender-Atik R, Brewin J, Hinshaw K, Choudhary M, Ahmed A, Naftalin J, Nunes N, Oliver A, Izzat F, Bhatia K, Hassan I, Jeve Y, Hamilton J, Deb S, Bottomley C, Ross J, Watkins L, Underwood M, Cheong Y, Kumar CS, Gupta P, Small R, Pringle S, Hodge F, Shahid A, Gallos ID, Horne AW, Quenby S, Coomarasamy A. Chu JJ, et al. Among authors: hassan i. Lancet. 2020 Sep 12;396(10253):770-778. doi: 10.1016/S0140-6736(20)31788-8. Epub 2020 Aug 24. Lancet. 2020. PMID: 32853559 Free PMC article. Clinical Trial.
Dermoscopy of Morphea.
Bhat YJ, Akhtar S, Hassan I. Bhat YJ, et al. Among authors: hassan i. Indian Dermatol Online J. 2019 Jan-Feb;10(1):92-93. doi: 10.4103/idoj.IDOJ_350_17. Indian Dermatol Online J. 2019. PMID: 30775314 Free PMC article. No abstract available.
Female Pattern Hair Loss-An Update.
Bhat YJ, Saqib NU, Latif I, Hassan I. Bhat YJ, et al. Among authors: hassan i. Indian Dermatol Online J. 2020 Jul 13;11(4):493-501. doi: 10.4103/idoj.IDOJ_334_19. eCollection 2020 Jul-Aug. Indian Dermatol Online J. 2020. PMID: 32832434 Free PMC article. Review.
The wisdom in ISCHEMIA.
Thomas B, Hassan I. Thomas B, et al. Among authors: hassan i. Indian Heart J. 2020 Nov-Dec;72(6):623-624. doi: 10.1016/j.ihj.2020.11.001. Epub 2020 Nov 6. Indian Heart J. 2020. PMID: 33357658 Free PMC article. Review.
924 results